We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$35.4B
AUM Growth
+$439M
(+1.3%)
Cap. Flow
-$1.77B
Cap. Flow
% of AUM
-5.01%
Top 10 Holdings %
Top 10 Hldgs %
52.34%
Holding
71
New
5
Increased
16
Reduced
44
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$260M |
| 2 |
Edwards Lifesciences
EW
|
+$214M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$175M |
| 4 |
Alibaba
BABA
|
+$130M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$535M |
| 2 |
Starbucks
SBUX
|
+$297M |
| 3 |
Baidu
BIDU
|
+$279M |
| 4 |
Visa
V
|
+$175M |
| 5 |
Netflix
NFLX
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.64% |
| 2 | Technology | 23.61% |
| 3 | Healthcare | 21.16% |
| 4 | Communication Services | 16.27% |
| 5 | Financials | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.48T
| $2.92B | 8.26% |
29,155,440
-5,691,300
| -16% | -$535M |
|
|
2
Visa
V
$697B
| $2.61B | 7.38% |
17,392,997
-1,231,524
| -7% | -$175M |
|
|
3
Alibaba
BABA
$276B
| $2.53B | 7.15% |
15,341,387
+731,838
| +5% | +$130M |
|
|
4
Netflix
NFLX
$301B
| $1.97B | 5.57% |
52,669,200
-3,896,760
| -7% | -$141M |
|
5
Alphabet (Google) Class A
GOOGL
$4.08T
| $1.53B | 4.33% |
25,373,380
-1,796,420
| -7% | -$109M |
|
6
Illumina
ILMN
$29.2B
| $1.47B | 4.16% |
4,115,260
-274,702
| -6% | -$88M |
|
|
7
Edwards Lifesciences
EW
$48.2B
| $1.46B | 4.12% |
25,121,898
+4,369,602
| +21% | +$214M |
|
8
Salesforce
CRM
$149B
| $1.39B | 3.94% |
8,769,989
-757,236
| -8% | -$112M |
|
9
Meta Platforms (Facebook)
META
$1.51T
| $1.34B | 3.78% |
8,137,313
-547,559
| -6% | -$99.1M |
|
10
ServiceNow
NOW
$114B
| $1.29B | 3.64% |
32,938,240
-2,517,655
| -7% | -$95.2M |
|
11
Booking.com
BKNG
$154B
| $1.15B | 3.27% |
14,551,375
-1,083,775
| -7% | -$85.3M |
|
12
Adobe
ADBE
$99B
| $1.13B | 3.2% |
4,185,608
-434,050
| -9% | -$112M |
|
13
Align Technology
ALGN
$12.6B
| $1.11B | 3.15% |
2,844,202
-215,156
| -7% | -$79.4M |
|
|
SCHW
14
Charles Schwab
SCHW
$184B
| $1.05B | 2.97% |
21,375,369
-1,526,903
| -7% | -$78M |
|
15
Workday
WDAY
$39.4B
| $948M | 2.68% |
6,492,283
-420,686
| -6% | -$58.4M |
|
16
Regeneron Pharmaceuticals
REGN
$72.9B
| $880M | 2.49% |
2,177,393
-128,418
| -6% | -$48.9M |
|
17
Palo Alto Networks
PANW
$260B
| $736M | 2.08% |
19,607,466
-1,658,628
| -8% | -$60.4M |
|
18
Monster Beverage
MNST
$95.6B
| $689M | 1.95% |
23,658,530
+409,522
| +2% | +$12.3M |
|
19
Nike
NKE
$63.9B
| $670M | 1.89% |
7,909,434
-457,050
| -5% | -$36.7M |
|
20
BioMarin Pharmaceuticals
BMRN
$12B
| $625M | 1.77% |
6,446,545
-483,654
| -7% | -$48.3M |
|
21
ASML
ASML
$608B
| $618M | 1.75% |
3,288,072
-131,465
| -4% | -$26.4M |
|
|
SPLK
22
DELISTED
Splunk Inc
SPLK
| $611M | 1.73% |
5,049,750
-431,722
| -8% | -$47.8M |
|
23
CoStar Group
CSGP
$12.4B
| $605M | 1.71% |
14,385,560
-305,950
| -2% | -$13.1M |
|
|
ATVI
24
DELISTED
Activision Blizzard
ATVI
| $544M | 1.54% |
6,537,568
+919,612
| +16% | +$69.8M |
|
25
Shopify
SHOP
$169B
| $460M | 1.3% |
27,958,760
-1,460,450
| -5% | -$22.2M |
|
Similar funds
KK
VAI
UIM
SO
Sands Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Sands Capital Management held 71 positions worth $35.4B, up 1.3% from $34.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sands Capital Management withdrew a net $1.77B in Q3 2018, closing 3 positions and reducing 44 holdings. Its most notable exit was Credicorp, an estimated $49.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Sands Capital Management opened a new position in Sarepta Therapeutics worth $307M.
- Sands Capital Management's largest Q3 2018 buy was Sarepta Therapeutics: 1,901,564 shares worth $307M.
- Sands Capital Management added most to Edwards Lifesciences in Q3 2018, an estimated $214M increase.
- Sands Capital Management's biggest Q3 2018 reduction was Amazon, cutting an estimated $535M.
- Sands Capital Management fully exited Credicorp in Q3 2018, selling an estimated $49.8M.
- Sands Capital Management's ten largest holdings make up 52% of its $35.4B portfolio in Q3 2018.
- Sands Capital Management opened 5 new positions and closed 3 in Q3 2018.
- Sands Capital Management's portfolio value rose 1.3% quarter-over-quarter to $35.4B.
Based on Sands Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.